0001415889-24-013498.txt : 20240517
0001415889-24-013498.hdr.sgml : 20240517
20240517161715
ACCESSION NUMBER: 0001415889-24-013498
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240515
FILED AS OF DATE: 20240517
DATE AS OF CHANGE: 20240517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SEIDENBERG BETH C
CENTRAL INDEX KEY: 0001184592
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40407
FILM NUMBER: 24959960
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001831828
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 812744449
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8000 MARINA BOULEVARD, SUITE 120
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 650-770-0077
MAIL ADDRESS:
STREET 1: 8000 MARINA BOULEVARD, SUITE 120
CITY: BRISBANE
STATE: CA
ZIP: 94005
4
1
form4-05172024_080552.xml
X0508
4
2024-05-15
0001831828
Vera Therapeutics, Inc.
VERA
0001184592
SEIDENBERG BETH C
C/O VERA THERAPEUTICS, INC.
8000 MARINA BOULEVARD, SUITE 120
BRISBANE
CA
94005
true
false
false
false
0
Stock Option (right to buy)
42.69
2024-05-15
4
A
0
14000
0
A
2034-05-14
Class A Common Stock
14000
14000
D
The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2025 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.
/s/ Joseph R. Young, Attorney-in-Fact
2024-05-17